Celgene

Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
CP Wire
Wed, 10/10/18 - 10:10 am
Celgene
ozanimod
multiple sclerosis
Celgene Reports Positive Results from New Analyses of Ozanimod in Multiple Sclerosis
Wed, 10/10/18 - 09:50 am
Celgene
ozanimod
multiple sclerosis
Celgene notches positive Otezla data in scalp psoriasis as it guns for market expansion
Fierce Pharma
Tue, 10/9/18 - 11:23 pm
Celgene
Otezla
scalp psoriasis
FDA
Drumbeat of bad news continues at OncoMed as Celgene dumps option on one of its last pipeline efforts
Endpoints
Thu, 09/20/18 - 11:11 am
OncoMed
Celgene
navicixizumab
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Fri, 09/14/18 - 11:59 pm
Bluebird Bio
Amgen
Celgene
AMG-420
bb2121
Celgene's CEO Wants to Make the Biotech's Best-Selling Drug Obsolete
Motley Fool
Fri, 09/7/18 - 11:28 am
Revlimid
Celgene
Pharma CEOs
Mark Alles
The reinvention of Bob Hugin: Amid anger over drug prices, a former pharma CEO makes a run for the Senate
Stat
Thu, 09/6/18 - 09:33 am
Bob Hugin
Celgene
Pharma CEOs
Senate
politics
Bristol-Myers (BMY) sBLA for Empliciti Gets Priority Review
Yahoo/Zacks.com
Fri, 08/24/18 - 11:08 am
Bristol-Myers Squibb
Empliciti
Celgene
Pomalyst
Multiple Myeloma
Can Celgene’s Most Important Drugs Keep Growing?
Motley Fool
Sun, 07/29/18 - 11:01 am
Celgene
Multiple Myeloma
Celgene (CELG) Beats on Q2 Earnings, Ups View
Marketwatch
Thu, 07/26/18 - 11:06 pm
Celgene
earnings
BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China
CP Wire
Wed, 07/25/18 - 03:11 pm
BeiGene
Celgene
tislelizumab
China
monoclonal antibodies
Can Celgene's latest Revlimid win reverse the company's bad-news streak?
Fierce Pharma
Tue, 07/24/18 - 06:00 pm
Celgene
Revlimid
clinical trials
Roche
Rituxan
non-Hodgkin lymphoma
Number 7? Celgene partner BeiGene joins the crowd with stellar PD-1/L1 data from a pivotal test
Endpoints
Mon, 07/23/18 - 09:45 am
Celgene
BeiGene
tiselizumab
Hodgkin's lymphoma
7 companies to watch during Q2 earnings
Biopharma Dive
Sun, 07/22/18 - 12:41 pm
earnings
Biogen
Gilead Sciences
Amgen
Celgene
AbbVie
Pfizer
Spark Therapeutics
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Wed, 07/18/18 - 10:49 pm
Celgene
Novartis
ozanimod
Gilenya
MS
multiple sclerosis
patents
Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology
BioSpace
Tue, 07/17/18 - 11:23 pm
Presage Biosciences
Takeda
Celgene
cancer
diagnostics
Many Drugmakers Ignore Trump—and Raise Prices Anyway
Bloomberg
Sun, 07/15/18 - 12:52 pm
drug pricing
Donald Trump
Pfizer
Celgene
Roche
Novo Nordisk
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
Fierce Pharma
Fri, 07/13/18 - 11:52 am
patents
Novartis
MS
Gilenya
Celgene
exclusivity
Celgene tweaks trial of myeloma CAR-T bb2121, raising dose
Fierce Biotech
Fri, 07/13/18 - 09:44 am
Celgene
clinical trials
bb2121
Bluebird Bio
Multiple Myeloma
CAR-T

Pages